Scalper1 News
Just how many biotech IPOs can one market take? Investors might be asking themselves this question as the explosion of new issues in the sector shows no sign of slowing for a third straight year. RBC Capital Markets counts 29 IPOs in the sector this year through Friday — putting 2015 possibly on pace to pass 2014, when 67 biotechs debuted “in line with the previous peak in 2000,” said RBC analyst Michael Yee in a research report. Yee said that the Scalper1 News
Scalper1 News